β2-adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4

Journal of Cardiovascular Pharmacology

Volumn 56, Issue 5, 2010, Pages 548-559

  Larocca, Thomas J ^a   Schwarzkopf, Martina ^a   Altman, Perry ^a   Zhang, Shihong ^a   Gupta, Achla ^b   Gomes, Ivone ^b   Alvin, Zikiar ^d   Champion, Hunter C ^c   Haddad, Georges ^d   Hajjar, Roger J ^a   Devi, Lakshmi A ^b   Schecter, Alison D ^e   Tarzami, Sima T ^a  

^a Cardiovascular Center   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d HOWARD UNIVERSITY   (United States)

^e NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

beta adrenergic receptors; chemokines; dimerization; g protein coupled receptors; heart failure

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CHEMOKINE RECEPTOR CXCR4; GUANINE NUCLEOTIDE BINDING PROTEIN; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

ADRENERGIC BETA-AGONISTS; ANIMALS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ISOPROTERENOL; MYOCYTES, CARDIAC; PHOSPHORYLATION; RATS; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, CXCR4; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 78650172422     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181f713fe     Document Type: Article

References (47)

1. Guyon A, Rovere C, Cervantes A, et al. Stromal cell-derived factor-1alpha directly modulates voltage-dependent currents of the action potential in mammalian neuronal cells. J Neurochem. 2005;93:963-973.
2. Hong F, Tuyama A, Lee TF, et al. Hepatic stellate cells express functional cxcr4: Role in stromal cell-derived factor-1alpha-mediated stellate cell activation. Hepatology. 2009;49:2055-2067.
3. Panicot-Dubois L, Thomas GM, Furie BC, et al. Bile salt-dependent lipase interacts with platelet cxcr4 and modulates thrombus formation in mice and humans. J Clin Invest. 2007;117:3708-3719.
4. Lohse MJ, Engelhardt S, Eschenhagen T. What is the role of beta-adrenergic signaling in heart failure? Circ Res. 2003;93:896-906.
5. Saxena A, Fish JE, White MD, et al. Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction. Circulation. 2008;117:2224-2231.
6. Hu X, Dai S, Wu WJ, et al. Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha cxcr4 axis. Circulation. 2007; 116:654-663.
7. Askari AT, Unzek S, Popovic ZB, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet. 2003;362:697-703.
8. Chen J, Chemaly E, Liang L, et al. Effects of cxcr4 gene transfer on cardiac function after ischemia-reperfusion injury. Am J Pathol. 2010; 176:1705-1715.
9. Jujo K, Hamada H, Iwakura A, et al. Cxcr4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc Natl Acad Sci USA. 2010;107: 11008-11013.
10. Dai S, Yuan F, Mu J, et al. Chronic amd3100 antagonism of sdf-1alpha-cxcr4 exacerbates cardiac dysfunction and remodeling after myocardial infarction. J Mol Cell Cardiol. 2010;49:587-597.
11. Agarwal U, Ghalayini W, Dong F, et al. Role of cardiac myocyte cxcr4 expression in development and left ventricular remodeling after acute myocardial infarction. Circ Res. 2010;107:667-676.
12. Limatola C, Giovannelli A, Maggi L, et al. Sdf-1alpha-mediated modulation of synaptic transmission in rat cerebellum. Eur J Neurosci. 2000;12:2497-2504.
13. Skrzydelski D, Guyon A, Dauge V, et al. The chemokine stromal cell-derived factor-1/cxcl12 activates the nigrostriatal dopamine system. J Neurochem. 2007;102:1175-1183.
14. Guyon A, Nahon JL. Multiple actions of the chemokine stromal cell-derived factor-1alpha on neuronal activity. J Mol Endocrinol. 2007;38: 365-376.
15. Pyo RT, Sui J, Dhume A, et al. Cxcr4 modulates contractility in adult cardiac myocytes. J Mol Cell Cardiol. 2006;41:834-844.
16. Bristow MR, Ginsburg R, Umans V, et al. Beta 1-and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res. 1986;59:297-309.
17. Aukrust P, Damas JK, Gullestad L, et al. Chemokines in myocardial failure\pathogenic importance and potential therapeutic targets. Clin Exp Immunol. 2001;124:343-345.
18. Bettink SI, Werner C, Chen CH, et al. Integrin-linked kinase is a central mediator in angiotensin II type 1-and chemokine receptor cxcr4 signaling in myocardial hypertrophy. Biochem Biophys Res Commun. 2010;397: 208-213.
19. Tarzami ST, Calderon TM, Deguzman A, et al. Mcp-1/ccl2 protects cardiac myocytes from hypoxia-induced apoptosis by a g(alphai)-independent pathway. Biochem Biophys Res Commun. 2005;335: 1008-1016.
20. Ratajczak MZ, Majka M, Kucia M, et al. Expression of functional cxcr4 by muscle satellite cells and secretion of sdf-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Stem Cells. 2003;21:363-371.
21. Ganju RK, Brubaker SA, Meyer J, et al. The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane g-protein-coupled cxcr-4 receptor and activates multiple signal transduction pathways. J Biol Chem. 1998;273:23169-23175.
22. Kojima H, Sakurai K, Kikuchi K, et al. Development of a fluorescent indicator for nitric oxide based on the fluorescein chromophore. Chem Pharm Bull (Tokyo). 1998;46:373-375.
23. Gupta A, Decaillot FM, Gomes I, et al. Conformation state-sensitive antibodies to g-protein-coupled receptors. J Biol Chem. 2007;282: 5116-5124.
24. Calderon TM, Gertz SD, Sarembock IJ, et al. Induction of ig9 monocyte adhesion molecule expression in smooth muscle and endothelial cells after balloon arterial injury in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol. 2000;20:1293-1300.
25. Rios C, Gomes I, Devi LA. Mu opioid and cb1 cannabinoid receptor interactions: Reciprocal inhibition of receptor signaling and neurito-genesis. Br J Pharmacol. 2006;148:387-395.
26. Hamdan FF, Percherancier Y, Breton B, et al. Monitoring protein-protein interactions in living cells by bioluminescence resonance energy transfer (BRET). Curr Protoc Neurosci. 2006;Chapter 5:Unit 5.23.
27. Angers S, Salahpour A, Joly E, et al. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci USA. 2000;97:3684-3689.
28. Gomes I, Filipovska J, Devi LA. Opioid receptor oligomerization. Detection and functional characterization of interacting receptors. Methods Mol Med. 2003;84:157-183.
29. Friedman JE, Haddad GG. Major differences in ca2+i response to anoxia between neonatal and adult rat ca1 neurons: Role of ca2+o and na+o. J Neurosci. 1993;13:63-72.
30. Cotton JM, Kearney MT, Shah AM. Nitric oxide and myocardial function in heart failure: friend or foe? Heart. 2002;88:564-566.
31. Oxenoid K, Rice AJ, Chou JJ. Comparing the structure and dynamics of phospholamban pentamer in its unphosphorylated and pseudo-phosphor-ylated states. Protein Sci. 2007;16:1977-1983.
32. Rios CD, Jordan BA, Gomes I, et al. G-protein-coupled receptor dimerization: modulation of receptor function. Pharmacol Ther. 2001;92: 71-87.
33. Franco R, Casado V, Cortes A, et al. Basic concepts in g-protein-coupled receptor homo-and heterodimerization. Scientific World Journal. 2007;7: 48-57.
34. Percherancier Y, Berchiche YA, Slight I, et al. Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in cxcr4 homo-and heterodimers. J Biol Chem. 2005;280:9895-9903.
35. Pello OM, Martinez-Munoz L, Parrillas V, et al. Ligand stabilization of cxcr4/delta-opioid receptor heterodimers reveals a mechanism for immune response regulation. Eur J Immunol. 2008;38:537-549.
36. Hasbi A, Nguyen T, Fan T, et al. Trafficking of preassembled opioid mu-delta heterooligomer-gz signaling complexes to the plasma membrane: coregulation by agonists. Biochemistry. 2007;46:12997-13009.
37. Zhu WZ, Chakir K, Zhang S, et al. Heterodimerization of beta1-and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility. Circ Res. 2005;97:244-251.
38. Daaka Y, Luttrell LM, Lefkowitz RJ. Switching of the coupling of the beta2-adrenergic receptor to different g proteins by protein kinase a. Nature. 1997;390:88-91.
39. Catalucci D, Latronico MV, Ceci M, et al. Akt increases sarcoplasmic reticulum ca2+ cycling by direct phosphorylation of phospholamban at thr17. J Biol Chem. 2009;284:28180-28187.
40. Kemi OJ, Ceci M, Wisloff U, et al. Activation or inactivation of cardiac akt/mtor signaling diverges physiological from pathological hypertrophy. J Cell Physiol. 2008;214:316-321.
41. Granata R, Trovato L, Gallo MP, et al. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart. Cardiovasc Res. 2009; 83:303-312.
42. Pavoine C, Defer N. The cardiac beta2-adrenergic signalling a new role for the cpla2. Cell Signal. 2005;17:141-152.
43. Zou YR, Kottmann AH, Kuroda M, et al. Function of the chemokine receptor cxcr4 in haematopoiesis and in cerebellar development. Nature. 1998;393:595-599.
44. Wallukat G. The beta-adrenergic receptors. Herz. 2002;27:683-690.
45. Crow MT. Beta-adrenergic receptor signaling pathways mediating cell survival in cardiomyocytes: a role for pkc epsilon inhibition? J Mol Cell Cardiol. 2002;34:1121-1125.
46. Liang CS, Mao W, Liu J. Pro-apoptotic effects of anti-beta1-adrenergic receptor antibodies in cultured rat cardiomyocytes: actions on endoplasmic reticulum and the prosurvival pi3k-akt pathway. Autoimmunity. 2008;41:434-441.
47. Kovacs K, Hanto K, Bognar Z, et al. Prevalent role of akt and erk activation in cardioprotective effect of ca(2+) channel-and beta-adrenergic receptor blockers. Mol Cell Biochem. 2009;321:155-164.